- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.86 Å
- Oligo State
- hetero-2-2-2-2-mer
- Ligands
- 4 x FE: FE (III) ION(Non-covalent)
- 30 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 5 residues within 4Å:- Chain A: Y.340, W.341, P.377
- Chain D: A.21, F.25
Ligand excluded by PLIPEDO.4: 3 residues within 4Å:- Chain A: Q.406, W.407, A.410
Ligand excluded by PLIPEDO.5: 9 residues within 4Å:- Chain A: R.98, E.101, T.102, V.105, Y.288, L.289, G.293, A.359, L.361
Ligand excluded by PLIPEDO.6: 4 residues within 4Å:- Chain A: P.520, D.521, A.524, K.525
Ligand excluded by PLIPEDO.7: 8 residues within 4Å:- Chain A: V.105, F.109, G.178, L.180, G.357, F.358, A.359
- Ligands: EDO.8
Ligand excluded by PLIPEDO.8: 12 residues within 4Å:- Chain A: G.178, P.179, L.180, A.349, A.350, Y.351, M.353, W.354, L.356, G.357, L.361
- Ligands: EDO.7
Ligand excluded by PLIPEDO.9: 4 residues within 4Å:- Chain A: R.333, D.334, R.337, T.433
Ligand excluded by PLIPEDO.10: 8 residues within 4Å:- Chain A: N.268, T.269, N.272, E.327, S.328, P.329, A.330
- Chain C: Y.149
Ligand excluded by PLIPEDO.11: 8 residues within 4Å:- Chain A: R.186, G.191, N.203, N.273, A.274, T.277, Y.464
- Chain B: Q.77
Ligand excluded by PLIPEDO.12: 5 residues within 4Å:- Chain A: D.451, W.452, R.455
- Chain C: Y.149, L.153
Ligand excluded by PLIPEDO.14: 2 residues within 4Å:- Chain B: S.310, E.311
Ligand excluded by PLIPEDO.15: 7 residues within 4Å:- Chain A: F.79, L.83, F.153
- Chain B: E.51, W.108, H.110
- Chain H: K.97
Ligand excluded by PLIPEDO.16: 12 residues within 4Å:- Chain B: A.257, T.258, Q.261, R.265, F.291, R.295, V.364, D.367, W.368, D.371, Y.372
- Chain E: R.18
Ligand excluded by PLIPEDO.17: 8 residues within 4Å:- Chain C: R.4, I.12, Y.48, D.49, I.50, D.51, V.52, D.53
Ligand excluded by PLIPEDO.18: 8 residues within 4Å:- Chain A: R.77
- Chain D: S.45, E.47, K.97, F.99, D.103, I.106, N.107
Ligand excluded by PLIPEDO.19: 7 residues within 4Å:- Chain B: R.12
- Chain D: K.44, A.73, W.76
- Chain E: R.88, L.89, G.90
Ligand excluded by PLIPEDO.22: 6 residues within 4Å:- Chain E: R.173, H.486, V.488, R.489, S.490, G.492
Ligand excluded by PLIPEDO.23: 7 residues within 4Å:- Chain B: D.367, I.370
- Chain E: L.14, K.15, V.16, R.18
- Chain F: R.137
Ligand excluded by PLIPEDO.24: 5 residues within 4Å:- Chain E: L.409, D.414, P.520, P.522, K.525
Ligand excluded by PLIPEDO.25: 11 residues within 4Å:- Chain E: R.186, N.273, Q.456, E.460, R.463, Y.464
- Chain F: Q.77, H.80
- Chain G: N.145, Y.148
- Ligands: EDO.26
Ligand excluded by PLIPEDO.26: 12 residues within 4Å:- Chain E: R.186, G.191, E.199, N.203, D.270, N.273, A.274, T.277, R.463, Y.464
- Chain F: Q.77
- Ligands: EDO.25
Ligand excluded by PLIPEDO.27: 6 residues within 4Å:- Chain E: D.451, W.452, R.455
- Chain G: Y.149, P.152, L.153
Ligand excluded by PLIPEDO.28: 4 residues within 4Å:- Chain E: W.37, D.38
- Chain F: K.218, T.222
Ligand excluded by PLIPEDO.31: 11 residues within 4Å:- Chain B: F.126, Y.130, T.278, L.279, P.281, F.282
- Chain F: Q.269, P.281, T.284, A.285, Q.288
Ligand excluded by PLIPEDO.32: 7 residues within 4Å:- Chain D: K.97
- Chain E: F.79, L.83, F.153
- Chain F: E.51, W.108, H.110
Ligand excluded by PLIPEDO.33: 6 residues within 4Å:- Chain F: K.150, Y.151, V.216, K.219, I.220, K.344
Ligand excluded by PLIPEDO.34: 5 residues within 4Å:- Chain F: Y.142, A.343, K.344, V.345, E.346
Ligand excluded by PLIPEDO.35: 8 residues within 4Å:- Chain G: R.4, I.12, Y.48, D.49, I.50, D.51, V.52, D.53
Ligand excluded by PLIPEDO.36: 6 residues within 4Å:- Chain G: V.26, D.27, L.73, T.83, T.84, G.85
Ligand excluded by PLIPEDO.37: 11 residues within 4Å:- Chain E: R.77
- Chain H: S.45, E.47, I.48, I.51, F.99, D.103, L.104, I.106, N.107, V.108
Ligand excluded by PLIP- 2 x BEZ: BENZOIC ACID(Non-covalent)
BEZ.13: 16 residues within 4Å:- Chain A: L.110, G.113, E.114, A.117, E.144, F.188, F.192, L.204, G.208, E.209, T.213, L.216, I.217, E.243
- Ligands: FE.1, FE.2
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:L.110, A:F.188, A:F.188, A:E.209, A:T.213
BEZ.29: 17 residues within 4Å:- Chain E: L.110, G.113, E.114, A.117, E.144, F.188, F.192, L.204, G.208, E.209, F.212, T.213, L.216, I.217, E.243
- Ligands: FE.20, FE.21
6 PLIP interactions:6 interactions with chain E- Hydrophobic interactions: E:L.110, E:F.188, E:F.188, E:E.209, E:T.213, E:L.216
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jones, J.C. et al., Structural Studies of theMethylosinus trichosporiumOB3b Soluble Methane Monooxygenase Hydroxylase and Regulatory Component Complex Reveal a Transient Substrate Tunnel. Biochemistry (2020)
- Release Date
- 2020-08-05
- Peptides
- Methane monooxygenase component A alpha chain: AE
Methane monooxygenase: BF
Methane monooxygenase: CG
Methane monooxygenase regulatory protein B: DH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
EB
BF
FC
CG
GD
DH
H
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.86 Å
- Oligo State
- hetero-2-2-2-2-mer
- Ligands
- 4 x FE: FE (III) ION(Non-covalent)
- 30 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x BEZ: BENZOIC ACID(Non-covalent)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jones, J.C. et al., Structural Studies of theMethylosinus trichosporiumOB3b Soluble Methane Monooxygenase Hydroxylase and Regulatory Component Complex Reveal a Transient Substrate Tunnel. Biochemistry (2020)
- Release Date
- 2020-08-05
- Peptides
- Methane monooxygenase component A alpha chain: AE
Methane monooxygenase: BF
Methane monooxygenase: CG
Methane monooxygenase regulatory protein B: DH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
EB
BF
FC
CG
GD
DH
H